v**********m
发帖数: 5516 | 1 这家公司有人玩过吗？
ATryn都已经在EU 和USA 批准上市了，可结局居然是被廉价收购。
Acquisition of GTC Biotherapeutics, Inc. by LFB Biotechnologies S.A.S.
Completed
By: GTC Biotherapeutics, Inc. via Business Wire News Releases
Posted on December 06, 2010 at 08:00 AM EST
GTC Biotherapeutics, Inc. (“GTC” OTCBB: GTCB.OB) announced today that it
had completed its previously announced sale of approximately 61,100,000
shares of its common stock, par value $0.01 per share, to LFB
Biotechnologies S.A.S., Les Ulis, France (“LFB”) in a private placement
for $0.30 per share, for an aggregate purchase price of approximately $18.3
million. Following the private placement and the conversion of convertible
preferred stock of GTC owned by LFB, LFB owned at least 90% of GTC’s
outstanding common stock.
After LFB contributed all shares of GTC common stock it held to its wholly-
owned subsidiary, LFB Merger Sub, Inc. (“Merger Sub”), Merger Sub effected
a short-form merger in accordance with Massachusetts law merging itself
with and into GTC, with GTC being the surviving corporation in the merger,
and cashing out all minority shareholders for $0.30 per share, for an
aggregate purchase price of approximately $2.7 million. The merger became
effective on December 2, 2010. Following the effective time of the merger,
GTC became a wholly-owned subsidiary of LFB, and shares of GTC common stock
ceased to trade on the over-the-counter market.
Contacts:
GTC Biotherapeutics, Inc.
William K. Heiden, 508-370-5277
Chairman, President and Chief Executive Officer
w************[email protected] |
|
